Clinical Trial Update: Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluating bevacizumab with temozolomide in older patients with newly diagnosed glioblastoma or gliosarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Giant Cell Glioblastoma, Glioblastoma | Phase 2 | Status: COMPLETED